Virus Filtration Market to Grow with a CAGR of 7.25% through 2028
Growing biopharmaceutical industry and
expanding research and development activities are factors driving the Global
Virus Filtration Market in the forecast period 2024-2028.
According to TechSci Research report, “Virus
Filtration Market – Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2028”, the Global Virus Filtration Market
stood at USD 4.52 billion in 2022 and is anticipated to grow with a CAGR of 7.25%
in the forecast period, 2024-2028. The global virus filtration market has been on a
remarkable growth trajectory in recent years, primarily due to the increasing
demand for safe and effective viral clearance in biopharmaceutical
manufacturing, vaccines, and blood products. This market is driven by several
key factors, which collectively contribute to its expansion. The biopharmaceutical industry has witnessed
significant growth in recent years, with a surge in research and development
activities, as well as the introduction of novel biologics and biosimilars.
Virus filtration plays a pivotal role in ensuring the safety and quality of
these products, driving the demand for virus filtration technologies. The
increasing number of biopharmaceutical companies and the expansion of existing
ones contribute to the market's growth.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global Virus
Filtration Market.”
Government regulatory bodies and
agencies around the world have set stringent guidelines and standards for the
production and distribution of pharmaceuticals, vaccines, and blood products.
Virus filtration is a critical step in ensuring product safety and efficacy. As
regulations become more stringent, companies are compelled to adopt advanced
virus filtration technologies to meet compliance standards, thus driving market
growth. The global demand for vaccines has surged in recent years, driven by
growing awareness of the importance of immunization, the need to combat
emerging infectious diseases, and increasing government initiatives for
vaccination programs. Virus filtration is crucial for ensuring the safety of
vaccines by removing viral contaminants, which is propelling the market
forward.
The need for safe and reliable blood
products has led to a significant increase in the use of virus filtration in
the blood screening process. This is especially important in preventing the
transmission of blood-borne diseases such as HIV, hepatitis, and others. As
healthcare organizations focus on providing safer blood transfusions, the virus
filtration market continues to grow. Innovation in virus filtration
technologies, such as membrane materials and design, has made these processes
more efficient and cost-effective. The development of novel materials, such as
nanomaterials and high-flux membranes, has improved the efficacy and throughput
of virus filtration systems, making them more attractive to end-users.
The Global Virus Filtration Market is segmented into product,
technology, end use and
company.
Based on end use, the biopharmaceutical and
biotechnology companies segment has emerged as the predominant market leader. Biopharmaceutical and biotechnology companies are
often at the forefront of innovation in the healthcare industry. They possess
specialized expertise in developing and manufacturing complex biopharmaceutical
products, including monoclonal antibodies, gene therapies, and vaccines. These
products demand cutting-edge virus filtration technologies to ensure their
safety and purity. The
biopharmaceutical sector is heavily regulated, and stringent guidelines require
thorough virus removal during production. Biopharmaceutical and biotechnology
companies are well-equipped to meet these regulatory demands due to their
extensive experience and resources dedicated to compliance. Biopharmaceutical and biotechnology companies invest
heavily in research and development to create novel therapies and drugs. These
investments extend to developing advanced virus filtration techniques, such as
nanofiltration and ultrafiltration, which are crucial for ensuring product
safety.
Based on region, North America segment is expected to
grow during the forecast period. North America's dedication to
research and development is a key driver of its dominance in the global virus
filtration market. Companies in the region consistently invest in cutting-edge
filtration technologies, resulting in continuous advancements in virus removal
and reduction processes. This commitment to innovation has given North American
firms a competitive edge in the global market. North America is home to several industry giants in
the virus filtration market. Companies such as Merck & Co., Inc., Pall
Corporation, and Sartorius AG have established themselves as leaders in the
field. Their expertise and technological innovations have helped North America
maintain its competitive advantage and dominate the global virus filtration
market.
The Asia Pacific region is experiencing rapid market
growth. As the
biopharmaceutical industry evolves, the need for efficient and reliable virus
filtration technologies will only become more pronounced. The companies in Asia
Pacific are well-positioned to meet these demands and maintain their leadership
role in the industry.
Major companies operating in Global Virus
Filtration Market are:
- Merck KGaA
- Danaher Corporation
- Sartorius AG
- Thermo Fisher Scientific Inc.
- GE Healthcare Technologies,
Inc.
- Charles River Laboratories
- Asahi Kasei Medical Co., Ltd.
- WuXi AppTec
- Lonza Group AG
- Clean Biologics
Download
Free Sample Report
Customers can also request 10% free
customization on this report.
“The global
virus filtration market is experiencing robust growth, thanks to a confluence
of factors, including the expansion of the biopharmaceutical industry,
stringent regulatory requirements, increased vaccine production, a focus on
blood screening, technological advancements, rising awareness of viral
contamination, and expanding R&D activities. As these market drivers
continue to influence the industry, the virus filtration market is poised for
further expansion, meeting the ever-growing demand for safer and more effective
virus clearance in various sectors of healthcare and biotechnology.” said Mr.
Karan Chechi, Research Director with TechSci Research, a research-based
management consulting firm.
“Virus Filtration Market By Product
(Consumables (Kits and reagents, Others), Instruments (Filtration systems,
Chromatography systems), Services), Technology (Filtration, Chromatography), By
End use (Biopharmaceutical & biotechnology companies, Contract research
organizations, Medical device companies, Academic institutes & research
laboratories), By
Region, By Competition Forecast
& Opportunities, 2018-2028F”, has evaluated the future growth potential of Global
Virus Filtration Market and provides statistics & information on market
size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in Global Virus
Filtration Market.
Contact
Mr. Ken Mathews
Techsci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com